Skip to main content
Top
Published in: Current Heart Failure Reports 4/2012

01-12-2012 | Epidemiology of Heart Failure (J Butler, Section Editor)

Aging of the United States Population: Impact on Heart Failure

Authors: Rebecca Vigen, Thomas M. Maddox, Larry A. Allen

Published in: Current Heart Failure Reports | Issue 4/2012

Login to get access

Abstract

The United States population, particularly among older age groups, continues to expand. Because the incidence of heart failure increases with age, largely due to the development of heart failure risk factors such as hypertension and coronary artery disease, the epidemic of heart failure is likely to grow further in the coming decades. This article will review the epidemiology of heart failure among older adults, the influence of an aging population on heart failure prevalence and phenotype, the complications in management for a larger and older heart failure population, and the potential implications of these changes for health care costs and delivery. Ultimately, these challenges demand research into optimal therapeutic strategies for older heart failure patients, including improved prevention and treatment of the major causes of heart failure, an increasing role forpalliative care, and innovations in patient-centered health care delivery.
Literature
2.
go back to reference Werner CA. The Older Population: 2010. The 2010 Census Briefs, November 2011. Werner CA. The Older Population: 2010. The 2010 Census Briefs, November 2011.
3.
go back to reference National Institute on Aging NIH, U.S. Department of Health and Human Services, U.S. Department of State. Why Population Aging Matters: A Global Perspective. 2007:1–32. National Institute on Aging NIH, U.S. Department of Health and Human Services, U.S. Department of State. Why Population Aging Matters: A Global Perspective. 2007:1–32.
4.
go back to reference Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.PubMedCrossRef Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44.PubMedCrossRef
5.
go back to reference Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–e220.PubMedCrossRef Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–e220.PubMedCrossRef
6.
go back to reference National Institutes of Health: NHLBI. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. National Institutes of Health: NHLBI. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases.
7.
go back to reference National Institutes of Health: NHLBI. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Institutes of Health: NHLBI. Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases.
8.
go back to reference Butler J, Kalogeropoulos AP, Georgiopoulou VV, et al. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97(16):1304–11.PubMedCrossRef Butler J, Kalogeropoulos AP, Georgiopoulou VV, et al. Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart. 2011;97(16):1304–11.PubMedCrossRef
9.
go back to reference Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068–72.PubMedCrossRef Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106(24):3068–72.PubMedCrossRef
10.
go back to reference Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009;169(7):708–15.PubMedCrossRef Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009;169(7):708–15.PubMedCrossRef
11.
go back to reference Yoon S, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. NCHS Data Brief. 2010;48:1–8.PubMed Yoon S, Ostchega Y, Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999–2008. NCHS Data Brief. 2010;48:1–8.PubMed
12.
go back to reference Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction. Circulation. 2008;118(20):2057–62.PubMedCrossRef Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-Term Trends in the Incidence of Heart Failure After Myocardial Infarction. Circulation. 2008;118(20):2057–62.PubMedCrossRef
13.
go back to reference Mann D, Reynolds K, Smith D, Muntner P. Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines. Ann Pharmacother. 2008;42(9):1208–15.PubMedCrossRef Mann D, Reynolds K, Smith D, Muntner P. Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines. Ann Pharmacother. 2008;42(9):1208–15.PubMedCrossRef
14.
go back to reference Committee on Reducing Tobacco Use: Strategies B, Consequences. Ending the Tobacco Problem: A Blueprint for the Nation: The National Academies Press; 2007. Committee on Reducing Tobacco Use: Strategies B, Consequences. Ending the Tobacco Problem: A Blueprint for the Nation: The National Academies Press; 2007.
15.
go back to reference Yeh RW, Sidney S, Chandra M, et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med. 2010;362(23):2155–65.PubMedCrossRef Yeh RW, Sidney S, Chandra M, et al. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med. 2010;362(23):2155–65.PubMedCrossRef
16.
go back to reference Kannel WB. Incidence and epidemiology of heart failure. Hear Fail Rev. 2000;5(2):167–73.CrossRef Kannel WB. Incidence and epidemiology of heart failure. Hear Fail Rev. 2000;5(2):167–73.CrossRef
17.
go back to reference Murad K, Kitzman D. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Hear Fail Rev. 2012;17(4):581–8.CrossRef Murad K, Kitzman D. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Hear Fail Rev. 2012;17(4):581–8.CrossRef
18.
go back to reference Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age. Am J Cardiol. 2001;87(4):413–9.PubMedCrossRef Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥65 years of age. Am J Cardiol. 2001;87(4):413–9.PubMedCrossRef
19.
go back to reference Owan TE, Hodge DO, Herges RM, et al. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006;355(3):251–9.PubMedCrossRef Owan TE, Hodge DO, Herges RM, et al. Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction. N Engl J Med. 2006;355(3):251–9.PubMedCrossRef
20.
go back to reference •• Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction - Prevalence, Therapies, and Outcomes. Circulation. 2012. This study describes differences in demographics, comorbidities, prevalence, and outcomes among patients with heart failure and normal ejection fraction versus those with borderline and reduced ejection fraction who are hospitalized for heart failure. •• Steinberg BA, Zhao X, Heidenreich PA, et al. Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction - Prevalence, Therapies, and Outcomes. Circulation. 2012. This study describes differences in demographics, comorbidities, prevalence, and outcomes among patients with heart failure and normal ejection fraction versus those with borderline and reduced ejection fraction who are hospitalized for heart failure.
21.
go back to reference Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–6.PubMedCrossRef Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–6.PubMedCrossRef
22.
go back to reference Krum H, Hill J, Fruhwald F, et al. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Hear Fail. 2006;8(3):302–7.CrossRef Krum H, Hill J, Fruhwald F, et al. Tolerability of beta-blockers in elderly patients with chronic heart failure: the COLA II study. Eur J Hear Fail. 2006;8(3):302–7.CrossRef
23.
go back to reference Muzzarelli S, Maeder MT, Toggweiler S, et al. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy. Am J Cardiol. 2012;109(5):693–8.PubMedCrossRef Muzzarelli S, Maeder MT, Toggweiler S, et al. Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy. Am J Cardiol. 2012;109(5):693–8.PubMedCrossRef
24.
go back to reference • Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Hear J. 2009;30(4):478–86. This study compares the management and outcomes among octogenarians and younger adults hospitalized with heart failure across Europe. Management and outcomes are also compared across time, between 2000–2001 and 2004–2005.CrossRef • Komajda M, Hanon O, Hochadel M, et al. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Hear J. 2009;30(4):478–86. This study compares the management and outcomes among octogenarians and younger adults hospitalized with heart failure across Europe. Management and outcomes are also compared across time, between 2000–2001 and 2004–2005.CrossRef
25.
go back to reference Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592–9.PubMed Santangeli P, Di Biase L, Dello Russo A, et al. Meta-analysis: age and effectiveness of prophylactic implantable cardioverter-defibrillators. Ann Intern Med. 2010;153(9):592–9.PubMed
26.
go back to reference • Alsheikh-Ali AA, Trikalinos TA, Ruthazer R, et al. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J. 2011;161(1):204–9.e1. This study shows that the proportion of patients who die from nonarrhythmic versus arrhythmic death increases among patients with advanced heart failure and chronic kidney disease.PubMedCrossRef • Alsheikh-Ali AA, Trikalinos TA, Ruthazer R, et al. Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. Am Heart J. 2011;161(1):204–9.e1. This study shows that the proportion of patients who die from nonarrhythmic versus arrhythmic death increases among patients with advanced heart failure and chronic kidney disease.PubMedCrossRef
27.
go back to reference •• Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Int Med. 2011;26(10):1145–51. This retrospective cohort study of Medicare beneficiaries with heart failure describes the increasing incidence of comorbidities with age.CrossRef •• Ahluwalia SC, Gross CP, Chaudhry SI, et al. Change in comorbidity prevalence with advancing age among persons with heart failure. J Gen Int Med. 2011;26(10):1145–51. This retrospective cohort study of Medicare beneficiaries with heart failure describes the increasing incidence of comorbidities with age.CrossRef
28.
go back to reference van Kan GA, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275–86.CrossRef van Kan GA, Rolland Y, Houles M, Gillette-Guyonnet S, Soto M, Vellas B. The assessment of frailty in older adults. Clin Geriatr Med. 2010;26(2):275–86.CrossRef
29.
go back to reference Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–56.CrossRef Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–56.CrossRef
30.
go back to reference Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M158–66.CrossRef Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol Ser A Biol Sci Med Sci. 2001;56(3):M158–66.CrossRef
31.
go back to reference Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005;35(12):723–30.PubMedCrossRef Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005;35(12):723–30.PubMedCrossRef
32.
go back to reference Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52.PubMedCrossRef Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125(15):1928–52.PubMedCrossRef
33.
go back to reference Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes. 2011;4(1):68–75.PubMedCrossRef Dunlay SM, Shah ND, Shi Q, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes. 2011;4(1):68–75.PubMedCrossRef
34.
go back to reference Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226–33.PubMedCrossRef Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003;42(7):1226–33.PubMedCrossRef
35.
go back to reference Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777–81.PubMedCrossRef Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777–81.PubMedCrossRef
36.
go back to reference Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215–25.PubMedCrossRef Flather MD, Shibata MC, Coats AJS, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215–25.PubMedCrossRef
37.
go back to reference Cleland JGF, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338–45.PubMedCrossRef Cleland JGF, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27(19):2338–45.PubMedCrossRef
38.
go back to reference Bhuiyan T, Maurer M. Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma. Curr Cardiovasc Risk Rep. 2011;5(5):440–9.PubMedCrossRef Bhuiyan T, Maurer M. Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma. Curr Cardiovasc Risk Rep. 2011;5(5):440–9.PubMedCrossRef
39.
go back to reference Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, et al. Heart failure: the hidden problem of pain. J Pain Symptom Manag. 2009;38(5):698–707.CrossRef Goebel JR, Doering LV, Shugarman LR, Asch SM, Sherbourne CD, Lanto AB, et al. Heart failure: the hidden problem of pain. J Pain Symptom Manag. 2009;38(5):698–707.CrossRef
40.
go back to reference Bekelman DB, Havranek EP. Palliative care for patients with acute decompensated heart failure: an underused service? Nat Clin Pract Cardiovasc Med. 2008;5(5):250–1.PubMedCrossRef Bekelman DB, Havranek EP. Palliative care for patients with acute decompensated heart failure: an underused service? Nat Clin Pract Cardiovasc Med. 2008;5(5):250–1.PubMedCrossRef
Metadata
Title
Aging of the United States Population: Impact on Heart Failure
Authors
Rebecca Vigen
Thomas M. Maddox
Larry A. Allen
Publication date
01-12-2012
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 4/2012
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-012-0114-8

Other articles of this Issue 4/2012

Current Heart Failure Reports 4/2012 Go to the issue

Pathophysiology of Myocardial Failure (IS Anand, Section Editor)

Growth Differentiation Factor 15 in Heart Failure: An Update

Pathophysiology of Myocardial Failure (IS Anand, Section Editor)

Anemia and Iron Deficiency in Heart Failure

Prevention of Heart Failure After Myocardial Infarction (M St. John Sutton, Section Editor)

Imaging the Myocardial Microcirculation Post-Myocardial Infarction

Pathophysiology of Myocardial Failure (IS Anand, Section Editor)

Assessment of Ventricular Remodeling in Heart Failure Clinical Trials

Epidemiology of Heart Failure (J Butler, Section Editor)

Trends In Heart Failure Hospitalizations

Prevention of Heart Failure After Myocardial Infarction (M St. John Sutton, Section Editor)

Gender Differences in the Pathophysiology, Clinical Presentation, and Outcomes of Ischemic Heart Failure

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.